MedTrace Logo

Directly Observed Therapy in High Risk Populations in Newark, NJ

NCT00285883 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2006-02-28

No results posted yet for this study

Summary

30 patients with poor antiretroviral therapy compliance will be identified from our pool of patients at Saint Michael's Medical Center and be given Directly observed therapy.

Conditions

  • Directly Observed Therapy
  • HIV Infections

Interventions

DRUG

Invirase

DRUG

Norvir

Sponsors & Collaborators

Principal Investigators

  • Jihad Slim, MD · Saint Michael's Medical Center

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-04-30
Completion
2006-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00285883 on ClinicalTrials.gov